Stocktoria
VERU INC. VERU
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1990-07-19
VERU INC. statistics & valuation
Market cap$50.2M
P / B2.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | 34.7% | 46.4% | 77.7% | 78.2% |
| Operating margin | — | -214.2% | -575.5% | -211.5% | 21.2% |
| Net margin | — | -223.9% | -571.6% | -212.9% | 12.1% |
| FCF margin | — | -129.3% | -544.1% | -122.6% | -26.0% |
| Return on assets | -76.2% | -62.6% | -186.2% | -61.5% | 4.2% |
| Return on equity | -124.0% | -117.0% | -473.4% | -101.2% | 4.9% |
| Current ratio | 2.43 | 2.97 | 1.29 | 2.53 | 9.62 |
| Revenue growth | — | 3.6% | -58.6% | -35.8% | 43.8% |
Source: SEC EDGAR filings · CIK 0000863894 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.